Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	vesicle cargo loading	CTAGE4 CTAGE9 CTAGE6 SEC31A CTAGE8 CTAGE15 KIF13A	1.91e-07	36	245	7	GO:0035459
GeneOntologyCellularComponent	endoplasmic reticulum exit site	CTAGE4 CTAGE9 CTAGE6 SEC31A CTAGE8 CTAGE15	9.85e-06	42	249	6	GO:0070971
GeneOntologyCellularComponent	apical junction complex	MPDZ SYNPO NPHP4 SHROOM4 AMOT AFDN PARD3B SHROOM1 CTNND1	1.20e-04	158	249	9	GO:0043296
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C KDM6A UTY	3.39e-04	12	249	3	GO:0044666
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	POU6F2 EOGT FOXK2 KCNH8 SRF SYNPO ZSWIM1 ZNF236 TTC3 SLC30A4 CASZ1 TASOR2 KMT2C SENP1 HOXC4 FAM120A SMG7 TECPR2 TOX3 ARHGEF9 BOD1L1 CAMTA1 MLPH KDM6A MAML3 SLC37A1 ATRN CACNA1C UXS1 PCDHGB1 AFF3 TOM1 TRIOBP PARD3B PRPF38B ZSWIM6 KIAA1671 PPP2R2C USF3 PWWP2B MICAL2 LRP1 RBM6 RBM5 LSM14A GREB1 LRBA CTNND1 ATP2B1	1.10e-18	1489	257	49	28611215
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ATXN2L NET1 MPDZ EDC4 NEK4 ZCCHC14 USP31 MDN1 MAST4 AMOT SVIL ZBTB21 AFDN BOD1L1 MAP4K4 KIF13B IRS4 ARHGEF5 COBLL1 ZNF629 PARD3B KIAA1671 GRIP1 LATS1 MEPCE EXO1 PLEKHM3 CTNND1 KIF13A SRRM2 ATP2B1 DCP1A	7.69e-14	861	257	32	36931259
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L USP9X MPDZ EDC4 EMSY KMT2C SMG7 AMOT AFDN BOD1L1 MAP4K4 KDM6A SIN3B IRS4 KIAA1671 LATS1 CEBPZ ACIN1 LRBA CTNND1 SPEN DCP1A	1.80e-10	549	257	22	38280479
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	DDX42 SYNPO STOX1 TTC3 TASOR2 MDN1 TCHHL1 ZBTB21 BOD1L1 CTAGE4 ITIH6 MLPH KIF13B CACNA1C IRS4 PCDHGB1 PCDHGA7 PCDHGA6 PCLO CTAGE6 NFE2L3 LATS1 CEBPZ PCDHGA12 CTAGE8 MARF1 RBM5 CTAGE15 ACIN1 OGDHL LSM14A CEP295 NGLY1 SPEN ATP2B1	7.17e-10	1442	257	35	35575683
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L NPHP4 CASZ1 SHROOM4 SAMD9L MYO15B TTBK1 FAM120A IRF2BPL MAML3 TANGO6 PLIN4 KIF13B SIN3B COBLL1 ZNF629 USF3 ARHGAP28 FHDC1 PPP6R2	1.01e-09	493	257	20	15368895
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L CTTNBP2NL EMSY MDN1 PTPRC SVIL ZBTB21 AFDN IRF2BPL CDT1 MAP4K4 KDM6A MRTFA NACC1 EML4 PRPF38B PWWP2B LATS1 RBM6 EXO1 ACIN1 SRRM2 SPEN DCP1A	4.31e-09	774	257	24	15302935
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	USP9X MPDZ CTTNBP2NL NEK4 AMOT AFDN MAP4K4 IRS4 HDAC5 NACC1 KIAA1549 KIAA1671 GRIP1 LATS1 EXO1 CEP295 PPP6R2	4.64e-08	446	257	17	24255178
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK USP9X MPDZ SYNPO EDC4 TTC3 EMSY KIAA0319 SENP1 MDN1 FAM120A SVIL ZBTB21 AFDN MAP4K4 KIF13B SIN3B IQSEC3 NACC1 TRIOBP SEC31A LRP1 FRMPD3 CTNND1 PPP6R2	6.54e-08	963	257	25	28671696
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KIAA0319 SALL2 MDN1 MAST4 TECPR2 ZBTB5 ZNF629 CTNND1 SRRM2	8.52e-08	104	257	9	9205841
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SPART SYNPO CTTNBP2NL KMT2C MAST4 SMG7 TECPR2 AMOT ZBTB21 ZBTB5 ZC3H7B ADGRL2 MAP4K4 ZNF212 AKNA TRIOBP KIAA1549 CNTNAP2	1.02e-07	529	257	18	14621295
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TNIK ATXN2L DDX42 SPART EDC4 EMSY SMG7 ZBTB21 BOD1L1 PRR14L SIN3B IRS4 NACC1 PRPF38B TACC2 KIAA1671 EIF2S3 MEPCE ACIN1 LSM14A LRBA CTNND1 PPP6R2 DCP1A	1.46e-07	934	257	24	33916271
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	ATXN2L MPDZ FAM120A AMOT SVIL IRS4 ZNF629 EIF2S3 MEPCE RBM6 RBM5 ACIN1 CTNND1	1.55e-07	274	257	13	34244482
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SP3 SYNPO2 TASOR2 ZNF469 TONSL IRF2BPL CAMTA1 MRTFA IRS4 HDAC5 ARHGEF5 CCDC141 KIAA1671 USF3 LATS1 SPEN	1.61e-07	430	257	16	35044719
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	USP9X KDM6A UTY EIF2S3B EIF2S3	1.68e-07	18	257	5	12023983
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RIN3 FOXK2 SPEG EDC4 ZNF236 TTC3 NPHP4 ELAC2 CASZ1 ZCCHC14 KMT2C MDN1 PKD1 ZC3H7B RAD9A ANKRD13D AKNA PAPLN SYNE4 NR2F2 PWWP2B CSNK1G2 OGDHL LRBA SPEN TOP3A	2.38e-07	1105	257	26	35748872
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ATXN2L FOXK2 USP9X PPP1R13L CTTNBP2NL PRKD3 FAM120A AFDN STK39 MRTFA COBLL1 TACC2 RBM6 ACIN1 KIF13A SRRM2 SPEN	2.56e-07	503	257	17	16964243
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SECISBP2L TNIK FOXK2 RIPK1 USP9X ETV3 EDC4 PPP1R13L NEK4 SMG7 CRYBG1 CDT1 MAP4K4 MRTFA HDAC5 NACC1 TOM1 SEC31A SHROOM1 EIF2S3 CEP41 LSM14A CTNND1 PPP6R2 DCP1A	2.67e-07	1038	257	25	26673895
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SP3 FOXK2 GCM2 SRF ZNF467 ZCCHC14 KMT2C SALL2 AFDN MAML3 PHIP SIN3B POU2F2 TACC2 NR2F2 PHC1 BARHL1 TOP3A DCP1A RNF111	3.96e-07	709	257	20	22988430
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	C16orf90 TOPAZ1 STOX1 CTTNBP2NL KMT2C FREM2 SAMD9L MYO15B MDN1 AMOT PKD1 BOD1L1 ATRN SIN3B NACC1 PCLO PRPF38B KIAA1671 CSNK1G2 CEP295	7.09e-07	736	257	20	29676528
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SP3 FOXK2 NET1 MPDZ EDC4 CTTNBP2NL CASZ1 EMSY KMT2C MDN1 METTL18 ARHGEF9 CRYBG1 AFDN ZC3H7B SDC4 SIN3B UXS1 PIGK TOM1 TRIOBP PRPF38B KIAA1671 CEBPZ CSNK1G2 EIF2S3 RBM6 RBM5 LSM14A SPEN	8.05e-07	1497	257	30	31527615
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	TNIK SPART ZCCHC14 ATRN HDAC5 PCLO PCDHGA12 GREB1	1.20e-06	105	257	8	9628581
Pubmed	Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function.	SRF SYNPO PTPRC MRTFA	1.98e-06	13	257	4	29114040
Pubmed	Functional proteomics mapping of a human signaling pathway.	SPART PPP1R13L TTC3 PTPRC MAST4 PKD1 AFDN KDM6A FLT4 TOM1 NR2F2 GRIP1 POLI LRP1 KIF13A DCP1A RNF111	2.32e-06	591	257	17	15231748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNIK SPEG KIAA0319 ZCCHC14 USP31 ARHGEF9 BOD1L1 CAMTA1 IQSEC3 HDAC5 ZSWIM6 ACIN1 SRRM2 SPEN	2.43e-06	407	257	14	12693553
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	TASOR2 KMT2C FAM120A CRYBG1 BOD1L1 CDT1 KDM6A PHIP HDAC5 NACC1 PARD3B CCDC141 CEBPZ ACIN1 SPEN	2.58e-06	469	257	15	27634302
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TNIK ATXN2L DDX42 MPDZ PPP1R13L NEK4 ZCCHC14 FAM120A BOD1L1 PRR14L CDT1 MAP4K4 UBE2J1 PIGK CEBPZ RBM5 CEP295 CTNND1 DCP1A	2.69e-06	733	257	19	34672954
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SP3 GCM2 SRF ETV3 NR6A1 ZNF236 ZCCHC14 TOX3 ZBTB21 ZBTB5 KDM6A UTY MRTFA ZNF212 POU2F2 NR2F2 PHC1 ZSCAN5B ZSCAN5C ACIN1	2.93e-06	808	257	20	20412781
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SALL2 AMOT ZBTB21 MRTFA TANGO6 SIN3B IRS4 HDAC5 NACC1 PHC1 KIAA1671 LRP1 LRBA DCP1A	3.30e-06	418	257	14	34709266
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	SVIL ZBTB21 AFDN IRS4 ADCK2 PARD3B PRPF38B ACIN1 CTNND1 SRRM2 DCP1A	3.54e-06	255	257	11	15324660
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PDXDC1 TNIK USP31 SLC39A6 ADGRL2 MAP4K4 IRS4 TRIOBP PARD3B SEC31A GRIP1 LRBA CTNND1 ATP2B1	3.58e-06	421	257	14	36976175
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGB1 PCDHGA7 PCDHGA6 PCDHGA12	3.73e-06	15	257	4	23515096
Pubmed	cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development.	CTAGE9 RBFOX3 SEC31A CTAGE8	3.73e-06	15	257	4	30224460
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNIK MPDZ EDC4 PPP1R13L CTTNBP2NL MAST4 FAM120A KIAA1671 CTNND1 DCP1A	3.97e-06	209	257	10	36779422
Pubmed	Functional significance of isoform diversification in the protocadherin gamma gene cluster.	RBFOX3 PCDHGB1 PCDHGA7 PCDHGA6 PCDHGA12	4.95e-06	34	257	5	22884324
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	TNIK PPP1R13L ZCCHC14 SMG7 MAP4K4 PCLO GRIP1 LATS1 CTNND1 PPP6R2	5.76e-06	218	257	10	33378226
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ATXN2L RIPK1 USP9X SPART MPDZ AFDN BOD1L1 ADGRL2 MAP4K4 UBE2J1 COBLL1 SEC31A GRIP1 LATS1 EIF2S3 LRBA CTNND1 ATP2B1	6.45e-06	708	257	18	39231216
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNIK ZCCHC14 KMT2C SALL2 SMG7 AMOT CAMTA1 MRTFA HDAC5 TRIOBP	7.60e-06	225	257	10	12168954
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L USP9X SPART EMSY SALL2 SMG7 TONSL KIF13B HDAC5 ZNF629 TACC2 KIAA1671 RBM6 SPEN PPP6R2 TOP3A	9.24e-06	588	257	16	38580884
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ATXN2L FOXK2 DDX42 EDC4 EMSY SENP1 KIF13B ACIN1 GREB1 SRRM2 SPEN DCP1A	1.02e-05	341	257	12	32971831
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	FOXK2 KMT2C KDM6A ASXL3	1.29e-05	20	257	4	29785026
Pubmed	A census of human transcription factors: function, expression and evolution.	SP3 POU6F2 FOXK2 GCM2 SRF ETV3 NR6A1 ZNF236 HOXC4 SALL2 TOX3 CAMTA1 AKNA KIAA1549 POU2F2 NR2F2 NFE2L3 USF3 CEBPZ BARHL1	1.61e-05	908	257	20	19274049
Pubmed	A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-gamma gene cluster.	RBFOX3 PCDHGB1 PCDHGA7 PCDHGA6 PCDHGA12	1.82e-05	44	257	5	19029045
Pubmed	Human transcription factor protein interaction networks.	FOXK2 USP9X ETV3 EDC4 EMSY KMT2C SALL2 FAM120A SMG7 SVIL ZBTB21 IRF2BPL KDM6A TANGO6 SIN3B IRS4 HDAC5 NACC1 ZNF629 KIAA1671 MARF1 RBM6 LSM14A SRRM2 SPEN DCP1A	2.44e-05	1429	257	26	35140242
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	USP9X CASZ1 NEK4 MDN1 KDM6A UTY MAML3 DRP2 PIGK NACC1 MUC16 ADCK2 ASXL3 CEP295 SPEN ATP2B1	2.50e-05	638	257	16	31182584
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SMG7 AMOT SVIL MAP4K4 SIN3B IRS4 KIAA1549 KIAA1671 LRBA CTNND1	2.92e-05	263	257	10	34702444
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L MPDZ FREM2 FAM120A TONSL AFDN ZC3H7B MAP4K4 EML4 ARHGEF5 ZNF629 PAPLN EIF2S3 MARF1 PPP6R2 TOP3A	3.13e-05	650	257	16	38777146
Pubmed	UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development.	SRF KDM6A UTY	3.24e-05	9	257	3	23028370
Pubmed	Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.	USP9X MPDZ AMOT LATS1	3.83e-05	26	257	4	28720576
Pubmed	Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.	KMT2C KDM6A CTNND1	4.61e-05	10	257	3	22421440
Pubmed	Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.	USP9X DDX42 TONSL CDT1 RAD9A PRPF38B EIF2S3 TOP3A	5.12e-05	175	257	8	37866880
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGB1 PCDHGA7 PCDHGA6 PCDHGA12	5.19e-05	28	257	4	15347688
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	FOXK2 USP9X ETV3 MDN1 ZBTB5 BOD1L1 SIN3B MEPCE CTNND1 SPEN	5.25e-05	282	257	10	23667531
Pubmed	Polarity protein AF6 functions as a modulator of necroptosis by regulating ubiquitination of RIPK1 in liver diseases.	RIPK1 AFDN	5.44e-05	2	257	2	37828052
Pubmed	An H-YDb epitope is encoded by a novel mouse Y chromosome gene.	KDM6A UTY	5.44e-05	2	257	2	8944031
Pubmed	Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C.	KMT2C CNTNAP2	5.44e-05	2	257	2	34582124
Pubmed	Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5.	FAS RBM5	5.44e-05	2	257	2	12581154
Pubmed	The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development.	SRF MRTFA	5.44e-05	2	257	2	20428204
Pubmed	Direct downregulation of CNTNAP2 by STOX1A is associated with Alzheimer's disease.	STOX1 CNTNAP2	5.44e-05	2	257	2	22728895
Pubmed	RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition.	FAS RBM5	5.44e-05	2	257	2	18851835
Pubmed	MAL and ternary complex factor use different mechanisms to contact a common surface on the serum response factor DNA-binding domain.	SRF MRTFA	5.44e-05	2	257	2	16705166
Pubmed	Essential roles of the ANKRD31-REC114 interaction in meiotic recombination and mouse spermatogenesis.	ANKRD31 REC114	5.44e-05	2	257	2	37976262
Pubmed	An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers.	RBM6 RBM5	5.44e-05	2	257	2	10486216
Pubmed	RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours.	RBM6 RBM5	5.44e-05	2	257	2	17908320
Pubmed	MRTF-A/SRF signaling suppresses invasion of oral squamous cell carcinoma.	SRF MRTFA	5.44e-05	2	257	2	37154247
Pubmed	Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.	CEACAM7 CEACAM6	5.44e-05	2	257	2	10666389
Pubmed	KIF13B enhances the endocytosis of LRP1 by recruiting LRP1 to caveolae.	KIF13B LRP1	5.44e-05	2	257	2	24469637
Pubmed	A non-canonical role for the EDC4 decapping factor in regulating MARF1-mediated mRNA decay.	EDC4 MARF1	5.44e-05	2	257	2	32510323
Pubmed	SRF/MRTF-A and liver cirrhosis: Pathologic associations.	SRF MRTFA	5.44e-05	2	257	2	36601855
Pubmed	Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts.	SRF MRTFA	5.44e-05	2	257	2	24732378
Pubmed	A close correlation in the expression patterns of Af-6 and Usp9x in Sertoli and granulosa cells of mouse testis and ovary.	USP9X AFDN	5.44e-05	2	257	2	15509704
Pubmed	A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.	RBM6 RBM5	5.44e-05	2	257	2	10352938
Pubmed	Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.	SRF MRTFA	5.44e-05	2	257	2	25681733
Pubmed	Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons.	KDM6A UTY	5.44e-05	2	257	2	18434530
Pubmed	Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover.	USP9X AMOT	5.44e-05	2	257	2	27462448
Pubmed	MRTF: Basic Biology and Role in Kidney Disease.	SRF MRTFA	5.44e-05	2	257	2	34204945
Pubmed	The Ras target AF-6 is a substrate of the fam deubiquitinating enzyme.	USP9X AFDN	5.44e-05	2	257	2	9722616
Pubmed	Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.	KDM6A UTY	5.44e-05	2	257	2	27533081
Pubmed	Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability.	PKD1 CACNA1C	5.44e-05	2	257	2	25888683
Pubmed	REC114 Partner ANKRD31 Controls Number, Timing, and Location of Meiotic DNA Breaks.	ANKRD31 REC114	5.44e-05	2	257	2	31003867
Pubmed	Positive and negative selection on mammalian Y chromosomes.	KDM6A UTY	5.44e-05	2	257	2	15758204
Pubmed	Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation.	KDM6A UTY	5.44e-05	2	257	2	31097364
Pubmed	Actin dynamics control SRF activity by regulation of its coactivator MAL.	SRF MRTFA	5.44e-05	2	257	2	12732141
Pubmed	Nuclear actin and myocardin-related transcription factors control disuse muscle atrophy through regulation of Srf activity.	SRF MRTFA	5.44e-05	2	257	2	25344251
Pubmed	Ontogenic changes in CD95 expression on human leukocytes: prevalence of T-cells expressing activation markers and identification of CD95-CD45RO+ T-cells in the fetus.	PTPRC FAS	5.44e-05	2	257	2	12880639
Pubmed	SRF-MRTF signaling suppresses brown adipocyte development by modulating TGF-β/BMP pathway.	SRF MRTFA	5.44e-05	2	257	2	32603734
Pubmed	Dopamine receptor antagonists as potential therapeutic agents for ADPKD.	PKD1 HDAC5	5.44e-05	2	257	2	31059522
Pubmed	Nuclear transport of the serum response factor coactivator MRTF-A is downregulated at tensional homeostasis.	SRF MRTFA	5.44e-05	2	257	2	21799516
Pubmed	Epistatic interaction of genetic depression risk variants in the human subgenual cingulate cortex during memory encoding.	CACNA1C PCLO	5.44e-05	2	257	2	24643163
Pubmed	Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain.	EIF2S3B EIF2S3	5.44e-05	2	257	2	16325480
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	PDXDC1 FOXK2 RIPK1 CTTNBP2NL ELAC2 IRF2BPL MRTFA EML4 PRPF38B SEC31A CTNND1 SRRM2 DCP1A	5.67e-05	472	257	13	38943005
Pubmed	OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.	MPDZ SENP1 AMOT TRIOBP LATS1 ACIN1	6.06e-05	91	257	6	30472188
Pubmed	Cloning of the genes encoding two murine and human cochlear unconventional type I myosins.	USP9X MAST4 SPEN	6.30e-05	11	257	3	9119401
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	FOXK2 NET1 DDX42 TTC3 KMT2C PTPRC AMOT CRYBG1 BOD1L1 CAMTA1 MRTFA KIF13B ZNF212 TACC2 SEC31A ACIN1 OGDHL CEP295 KIF13A ATP2B1 DCP1A	6.35e-05	1084	257	21	11544199
Pubmed	The functional interactome landscape of the human histone deacetylase family.	USP9X EMSY MDN1 SVIL PHIP SIN3B HDAC5 CEBPZ ACIN1 SRRM2	6.44e-05	289	257	10	23752268
Pubmed	Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.	USP9X SENP1 FAM120A AMOT MAP4K4 IRS4 ZNF629 MEPCE	6.74e-05	182	257	8	32239614
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXK2 CASZ1 EMSY SALL2 MDN1 FAM120A ZBTB21 ADGRL2 SIN3B HDAC5 NACC1 POU2F2 NR2F2 LRP1 CTNND1 SPEN ATP2B1 DCP1A	7.86e-05	857	257	18	25609649
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ATXN2L SYNPO EDC4 PPP1R13L TASOR2 CACNA1C UXS1 ZNF212 TRIOBP TACC2 SEC31A GRIP1 RBM5 LSM14A	8.31e-05	560	257	14	21653829
Pubmed	Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes.	KDM6A EIF2S3B EIF2S3	8.35e-05	12	257	3	23210685
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	SECISBP2L SYNPO NPHP4 EMSY SVIL SIN3B TRIOBP KIAA1671 CEBPZ ACIN1 SRRM2	8.73e-05	361	257	11	30344098
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	TNIK USP9X SYNPO STOX1 AMOT STK39 WFS1 KIAA1549 GRIP1 MAP3K13 CTNND1 ATP2B1	9.65e-05	430	257	12	32581705
Interaction	BAG2 interactions	TNIK RIPK1 EDC4 PPP1R13L NPHP4 ELAC2 NEK4 SALL2 AMOT IRF2BPL BOD1L1 PRR14L KDM6A MRTFA TANGO6 KIF13B FLT4 HDAC5 EML4 FAS NR2F2 PHC1 KIAA1671 PPP2R2C SHROOM1 RAVER2 GREB1 SRRM2 SPEN	5.09e-10	622	243	29	int:BAG2
Interaction	YWHAG interactions	ATXN2L SYNPO2 NET1 SPEG MPDZ SYNPO EDC4 PYHIN1 NEK4 USP31 TTBK1 MDN1 MAST4 AMOT SVIL ZBTB21 AFDN BOD1L1 MAP4K4 KIF13B IRS4 HDAC5 ARHGEF5 COBLL1 ZNF629 PARD3B PRPF38B KIAA1671 GRIP1 SHROOM1 LATS1 MEPCE EXO1 ACIN1 PLEKHM3 LRBA CTNND1 KIF13A SRRM2 DCP1A PSD4	4.25e-09	1248	243	41	int:YWHAG
Interaction	GUSBP5 interactions	ETV3 EMSY ZCCHC14 SMG7 ZBTB5 SIN3B KIAA1671 CEP295 SPEN	2.92e-07	75	243	9	int:GUSBP5
Interaction	YWHAH interactions	ATXN2L RIN3 NET1 SPEG MPDZ EDC4 PYHIN1 ZCCHC14 USP31 MAST4 AMOT SVIL ZBTB21 AFDN BOD1L1 MAP4K4 KIF13B IRS4 HDAC5 ARHGEF5 COBLL1 ZNF629 PARD3B KIAA1671 GRIP1 SHROOM1 LATS1 MEPCE EXO1 PLEKHM3 LRBA CTNND1 SRRM2 DCP1A	4.59e-07	1102	243	34	int:YWHAH
Interaction	FHL2 interactions	ATXN2L SP3 POU6F2 FOXK2 SRF EMSY MYO15B AMOT TOX3 MRTFA CACNA1C SIN3B ZNF212 KIAA1671 RBM5 SPEN DCP1A RNF111	1.65e-06	396	243	18	int:FHL2
Interaction	SFN interactions	TNIK ATXN2L EDC4 NEK4 USP31 MAST4 AMOT SVIL ZBTB21 MAP4K4 KIF13B IRS4 HDAC5 ARHGEF5 COBLL1 ZNF629 PARD3B KIAA1671 GRIP1 LATS1 EXO1 KIF13A SRRM2 DCP1A	3.69e-06	692	243	24	int:SFN
Interaction	CTAGE1 interactions	CTAGE4 CTAGE6 CTAGE8 CTAGE15	4.09e-06	10	243	4	int:CTAGE1
Interaction	FXR1 interactions	TNIK ATXN2L RIN3 USP9X EDC4 TTC3 TASOR2 SENP1 FAM120A SMG7 ZBTB21 AFDN ZC3H7B MAP4K4 UXS1 HDAC5 NACC1 ZNF212 TRIOBP TACC2 KIAA1671 GRIP1 LSM14A	8.72e-06	679	243	23	int:FXR1
Interaction	ZYX interactions	SECISBP2L FOXK2 USP9X SPART NEK4 SMG7 AMOT SVIL ZC3H7B MRTFA DCAF15 KIAA1671 LATS1 PPP6R2 DCP1A	1.19e-05	329	243	15	int:ZYX
Interaction	WWTR1 interactions	ATXN2L MPDZ EDC4 EMSY SMG7 AMOT AFDN MAP4K4 KDM6A SIN3B IRS4 KIAA1671 LATS1 CEBPZ LRBA CTNND1	5.77e-05	422	243	16	int:WWTR1
Cytoband	7q35	CTAGE4 ARHGEF5 CTAGE6 CTAGE8 CNTNAP2 CTAGE15	6.69e-07	55	257	6	7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr7q35	CTAGE4 ARHGEF5 CTAGE6 CTAGE8 CNTNAP2 CTAGE15	1.99e-06	66	257	6	chr7q35
Cytoband	2q11.2-q12	MAP4K4 AFF3	3.12e-05	2	257	2	2q11.2-q12
GeneFamily	CTAGE family	CTAGE4 CTAGE9 CTAGE6 CTAGE8 CTAGE15	1.52e-07	15	162	5	907
GeneFamily	PDZ domain containing	SYNPO2 MPDZ SHROOM4 MAST4 AFDN PCLO PARD3B GRIP1 FRMPD3	9.37e-06	152	162	9	1220
GeneFamily	Potassium voltage-gated channels	KCNH8 KCNH6 KCNC2 KCNV1	4.41e-04	40	162	4	274
Coexpression	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	TNIK ZNF467 TTC3 PRKD3 AMOT PKD1 COBLL1 AFF3 PARD3B SYNE4 PHC1 LSM14A	6.47e-07	200	254	12	M7518
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	SECISBP2L KCNH8 SPEG TTC3 CASZ1 MDN1 MAST4 KCNC2 TOX3 IRF2BPL BOD1L1 CAMTA1 SLC37A1 CACNA1C RBFOX3 PCLO AFF3 KIAA1549 POU2F2 CCDC141 GRIP1 PPP2R2C CSNK1G2 ASXL3 CNTNAP2 OGDHL FRMPD3 KIF13A ATP2B1	1.24e-06	1106	254	29	M39071
Coexpression	GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN	SYNPO MYO15B AFDN CDT1 MAP4K4 KDM6A SDC4 MRTFA UXS1 FAS POLI	4.21e-06	199	254	11	M9959
Coexpression	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	RIN3 CEACAM7 CEACAM6 ZCCHC14 HOXC4 CRYBG1 EIF2S3	2.23e-05	87	254	7	MM851
Coexpression	YANG_BREAST_CANCER_ESR1_UP	MLPH WFS1 P4HTM GREB1 LRBA	2.42e-05	36	254	5	M18299
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L TNIK NR6A1 FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 FHDC1 MAP3K13 TMC5	4.29e-14	198	256	16	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	SECISBP2L SLC46A2 FREM2 MAST4 MLPH UTY PARM1 SFTPB COBLL1 PCLO AFF3 TACC2 CCDC141 FHDC1 MAP3K13	4.45e-13	192	256	15	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NR6A1 FREM2 MAST4 AFDN MLPH PARM1 SFTPB COBLL1 AFF3 PARD3B TACC2 CCDC141 MICAL2 CTNND1 TMC5	5.18e-13	194	256	15	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L TNIK FREM2 MAST4 MLPH SDC4 PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 FHDC1 MAP3K13	6.97e-13	198	256	15	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	FREM2 MAST4 MLPH SDC4 PARM1 SFTPB PCLO AFF3 TACC2 CCDC141 MICAL2 FHDC1 MAP3K13 TMC5	6.46e-12	191	256	14	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L TNIK FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 FHDC1 TMC5	7.44e-12	193	256	14	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L TNIK FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 FHDC1 TMC5	7.44e-12	193	256	14	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L TNIK CASZ1 FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 FHDC1	7.98e-12	194	256	14	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NR6A1 SHROOM4 FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 MAP3K13 TMC5	1.13e-11	199	256	14	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	NR6A1 FREM2 MAST4 MLPH SDC4 PARM1 SFTPB TACC2 CCDC141 MICAL2 MAP3K13 CTNND1 TMC5	7.69e-11	188	256	13	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L TNIK FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 FHDC1 MAP3K13	9.37e-11	191	256	13	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 PCLO AFF3 TACC2 CCDC141 NCMAP FHDC1 MAP3K13	1.00e-10	192	256	13	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 NCMAP MICAL2 FHDC1 MAP3K13	1.00e-10	192	256	13	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	FREM2 MAST4 MLPH SDC4 PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 FHDC1 MAP3K13	1.07e-10	193	256	13	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NR6A1 MAST4 AFDN MLPH PARM1 SFTPB COBLL1 PARD3B TACC2 MICAL2 LRBA CTNND1 TMC5	1.21e-10	195	256	13	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L NR6A1 FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 TACC2 CCDC141 MICAL2 MAP3K13 TMC5	1.56e-10	199	256	13	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NR6A1 FREM2 MAST4 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 MICAL2 MAP3K13 TMC5	1.56e-10	199	256	13	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASZ1 TOX3 STK39 MLPH MAML3 PCLO MUC16 TACC2 KIAA1671 GRIP1 RAVER2 MAP3K13 TMC5	1.66e-10	200	256	13	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TNIK SHROOM4 FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MAP3K13	7.67e-10	183	256	12	6847c1252d6bb105524f812658112517fd351eab
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	CEACAM6 NR6A1 CASZ1 MAST4 MLPH SDC4 PARM1 SFTPB TACC2 MICAL2 MAP3K13 TMC5	1.04e-09	188	256	12	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	SHROOM4 FREM2 MAST4 MLPH SDC4 PARM1 SFTPB AFF3 TACC2 CCDC141 MICAL2 FHDC1	1.11e-09	189	256	12	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 MAP3K13 TMC5	1.25e-09	191	256	12	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NR6A1 FREM2 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 MAP3K13 TMC5	2.00e-09	199	256	12	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASZ1 SVIL TOX3 MLPH MAML3 SLC37A1 MUC16 TACC2 GRIP1 RAVER2 MAP3K13 TMC5	2.11e-09	200	256	12	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Control\|World / group, cell type (main and fine annotations)	FREM2 MLPH PARM1 SFTPB COBLL1 AFF3 PARD3B TACC2 CCDC141 MICAL2 TMC5	4.01e-09	168	256	11	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	SECISBP2L FREM2 MAST4 MLPH PARM1 SFTPB AFF3 TACC2 CCDC141 MICAL2 FHDC1	8.26e-09	180	256	11	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)\|367C / Donor, Lineage, Cell class and subclass (all cells)	SLC46A2 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 NCMAP FHDC1 TMC5	1.04e-08	184	256	11	0ba243cbf69b4fe6ae100a7f0314317bec38026c
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	FREM2 MAST4 MLPH SDC4 PARM1 SFTPB AFF3 TACC2 CCDC141 MICAL2 TMC5	1.04e-08	184	256	11	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	SLC46A2 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 NCMAP FHDC1 TMC5	1.04e-08	184	256	11	2a8338e94937686a148b5433515700ca0f674058
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	SECISBP2L NR6A1 MAST4 TOX3 PARM1 SFTPB COBLL1 GRIP1 MAP3K13 LRBA TMC5	1.23e-08	187	256	11	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	MAST4 MLPH PARM1 SFTPB COBLL1 PCLO AFF3 SHROOM1 FHDC1 MAP3K13 TMC5	1.30e-08	188	256	11	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	FREM2 MAST4 PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 FHDC1 TMC5	1.61e-08	192	256	11	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 MAST4 TOX3 AFDN COBLL1 PCLO PARD3B TACC2 GRIP1 MAP3K13 LRBA	1.70e-08	193	256	11	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TNIK MAST4 AFDN ADGRL2 CACNA1C AFF3 LAMA2 PARD3B ASXL3 CNTNAP2 ARHGAP28	2.10e-08	197	256	11	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC3 KCNC2 PKD1 ADGRL2 CACNA1C RBFOX3 PCLO AFF3 MICAL2 CNTNAP2 ATP2B1	2.22e-08	198	256	11	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	KMT2C STK39 KDM6A UTY MAML3 AFF3 PARD3B ZSWIM6 GRIP1 RBM6 LRBA	2.33e-08	199	256	11	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L TNIK FREM2 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 FHDC1	2.33e-08	199	256	11	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNPO2 MPDZ SHROOM4 MAST4 STK39 ADGRL2 CACNA1C COBLL1 LAMA2 SHROOM1 KIAA1755	2.46e-08	200	256	11	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNPO2 MPDZ SHROOM4 MAST4 STK39 ADGRL2 CACNA1C COBLL1 LAMA2 SHROOM1 KIAA1755	2.46e-08	200	256	11	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FREM2 MLPH SDC4 PARM1 SFTPB TACC2 CCDC141 NCMAP MICAL2 FHDC1 TMC5	2.46e-08	200	256	11	b535323e18d9fb0dde1e0026df142c831e48c29f
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNPO2 MPDZ SHROOM4 MAST4 STK39 ADGRL2 CACNA1C COBLL1 LAMA2 SHROOM1 KIAA1755	2.46e-08	200	256	11	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNPO2 MPDZ SHROOM4 MAST4 STK39 ADGRL2 CACNA1C COBLL1 LAMA2 SHROOM1 KIAA1755	2.46e-08	200	256	11	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNPO2 MPDZ SHROOM4 MAST4 STK39 ADGRL2 CACNA1C COBLL1 LAMA2 SHROOM1 KIAA1755	2.46e-08	200	256	11	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	SYNPO2 MPDZ SHROOM4 MAST4 STK39 ADGRL2 CACNA1C COBLL1 LAMA2 SHROOM1 KIAA1755	2.46e-08	200	256	11	7136936d05ab344a560cf159684c881063b5430d
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MPDZ PRKD3 KCNC2 SVIL PARM1 COBLL1 NR2F2 GPR156 FRMPD3	4.36e-08	124	256	9	36dfc702a570e1a1a6dde09f38badf9023ea7287
ToppCell	BAL-Severe-cDC_3\|Severe / Compartment, Disease Groups and Clusters	ANKRD31 RIN3 HLA-DPA1 AMOT SVIL ARHGEF9 PARM1 AFF3 USF3 CTNND1	8.34e-08	177	256	10	939487a05311b66edfc3f44a7955fbf25266d6bf
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP9X USP31 MAST4 SLC39A6 KIF13B CACNA1C WFS1 PCLO SEC31A CNTNAP2	8.79e-08	178	256	10	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NR6A1 MAST4 TOX3 PARM1 KIF13B COMP SFTPB AFF3 TACC2 GRIP1	8.79e-08	178	256	10	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	NET1 AMOT SDC4 PARM1 CACNA1C AFF3 PARD3B CCDC141 NCMAP LRBA	1.03e-07	181	256	10	cc7ae1221a28bc404138a7efee0ad08a19cc3d86
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	CEACAM6 MAST4 TOX3 MLPH PARM1 SFTPB TACC2 GRIP1 MAP3K13 TMC5	1.26e-07	185	256	10	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	SYNPO2 SVIL KCNK6 PARM1 CACNA1C GARNL3 COBLL1 MICAL2 ARHGAP28 KIF13A	1.46e-07	188	256	10	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	SYNPO2 CASZ1 MAST4 SVIL ADGRL2 CACNA1C LAMA2 TACC2 CCDC141 ALPK2	1.54e-07	189	256	10	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	FREM2 MAST4 PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 MICAL2 FHDC1	1.62e-07	190	256	10	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SLC46A2 MLPH PARM1 SFTPB AFF3 TACC2 CCDC141 MICAL2 FHDC1 TMC5	1.62e-07	190	256	10	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	SYNPO2 CASZ1 MAST4 SVIL ADGRL2 CACNA1C LAMA2 TACC2 CCDC141 ALPK2	1.62e-07	190	256	10	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK TOX3 CRYBG1 AFDN KIF13B TACC2 ZSWIM6 GRIP1 LRBA TMC5	1.70e-07	191	256	10	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	FREM2 MAST4 MLPH PARM1 SFTPB COBLL1 TACC2 MICAL2 MAP3K13 TMC5	1.78e-07	192	256	10	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MAST4 MLPH SFTPB COBLL1 AFF3 PARD3B TACC2 MICAL2 MAP3K13 TMC5	1.78e-07	192	256	10	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	TOX3 AFDN MAP4K4 KDM6A PHIP ATRN EML4 PARD3B LRBA SRRM2	1.87e-07	193	256	10	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L SLC46A2 MLPH SDC4 PARM1 SFTPB TACC2 CCDC141 NCMAP FHDC1	1.87e-07	193	256	10	8646e573f2d2ff175f3d02bfdf214e65f3b614d3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 CASZ1 MAST4 TOX3 COBLL1 PCLO GRIP1 OGDHL MAP3K13 LRBA	1.87e-07	193	256	10	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	lung-Type_II_Pneumocytes\|lung / shred on tissue and cell subclass	SECISBP2L SLC46A2 MLPH SDC4 SFTPB COBLL1 CCDC141 MICAL2 ATP2B1	1.89e-07	147	256	9	8a3039de45b8087f8319e2e37329acf7278219b7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 CASZ1 FREM2 MAST4 TOX3 SDC4 COBLL1 PCLO GRIP1 MAP3K13	1.96e-07	194	256	10	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	Control-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	TNIK MAST4 PARM1 SFTPB EML4 AFF3 TACC2 CCDC141 MICAL2 FHDC1	1.96e-07	194	256	10	a01de094f7bfd099bcbb2f94224690a2efb887b4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L HLA-DPA1 PRKD3 BOD1L1 SLC37A1 COBLL1 AFF3 POU2F2 PWWP2B ATP2B1	2.06e-07	195	256	10	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L SLC46A2 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 FHDC1	2.06e-07	195	256	10	6617abca0009ad3d8731f515f91ab275f9ea4c40
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L SLC46A2 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 FHDC1	2.06e-07	195	256	10	fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP9X TTC3 KMT2C FAM120A BOD1L1 UTY PCLO SEC31A SRRM2 ATP2B1	2.06e-07	195	256	10	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L HLA-DPA1 PRKD3 BOD1L1 SLC37A1 COBLL1 AFF3 POU2F2 PWWP2B ATP2B1	2.06e-07	195	256	10	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 CASZ1 MAST4 AFDN COBLL1 PCLO PARD3B GRIP1 MAP3K13 LRBA	2.06e-07	195	256	10	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L SLC46A2 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 FHDC1	2.06e-07	195	256	10	3e24570def013d5b0b1ef1d7a5ced7dfd922590b
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP9X TTC3 KMT2C FAM120A BOD1L1 UTY PCLO SEC31A SRRM2 ATP2B1	2.06e-07	195	256	10	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L SLC46A2 MLPH SDC4 PARM1 SFTPB TACC2 CCDC141 NCMAP FHDC1	2.06e-07	195	256	10	37aa6e4123d37de4de42ca68d3020f2a7686ce02
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L FREM2 MLPH PARM1 SFTPB COBLL1 AFF3 TACC2 CCDC141 FHDC1	2.16e-07	196	256	10	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNC2 PKD1 ADGRL2 CACNA1C RBFOX3 PCLO AFF3 MICAL2 CNTNAP2 ATP2B1	2.16e-07	196	256	10	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L SLC46A2 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 FHDC1	2.16e-07	196	256	10	82b117be41f2e7d677a42d2a5198726eeccb16d0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 MAST4 TOX3 CRYBG1 AFDN COBLL1 PARD3B TACC2 GRIP1 LRBA	2.16e-07	196	256	10	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	cellseq-Epithelial-Epithelial_Alveolar\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SECISBP2L CEACAM6 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 FHDC1	2.16e-07	196	256	10	a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L FREM2 MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 FHDC1	2.26e-07	197	256	10	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SECISBP2L PPP1R13L MLPH PHIP SLC37A1 SFTPB CCDC141 IRAG2 OGDHL FRMPD3	2.26e-07	197	256	10	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	SECISBP2L MLPH SDC4 PARM1 SFTPB COBLL1 TACC2 CCDC141 FHDC1 TMC5	2.37e-07	198	256	10	92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC3 KCNC2 ADGRL2 CACNA1C RBFOX3 PCLO AFF3 MICAL2 CNTNAP2 ATP2B1	2.37e-07	198	256	10	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNC2 ADGRL2 CACNA1C RBFOX3 PCLO AFF3 GRIP1 MICAL2 CNTNAP2 ATP2B1	2.37e-07	198	256	10	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC3 KCNC2 ADGRL2 CACNA1C RBFOX3 PCLO AFF3 GRIP1 CNTNAP2 ATP2B1	2.37e-07	198	256	10	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Biopsy_Other_PF-Epithelial-AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	SLC46A2 FREM2 MLPH SDC4 PARM1 SFTPB TACC2 CCDC141 FHDC1 TMC5	2.48e-07	199	256	10	9a65acfe9bf500db72142469cf17bf0973540001
ToppCell	mild-B_memory\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KCNH8 HLA-DPA1 SYNPO PRKD3 PARM1 COBLL1 AFF3 CTAGE8 CNTNAP2 IRAG2	2.48e-07	199	256	10	e6ac9a0959b0de2c6a99298feb7715aa80ade1dd
ToppCell	mild-B_memory\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KCNH8 HLA-DPA1 SYNPO PRKD3 PARM1 UBE2J1 COBLL1 AFF3 CTAGE8 CNTNAP2	2.48e-07	199	256	10	025bb65629d9e20c374e8f1ba08c36d1bb569190
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	KCNC2 PKD1 ADGRL2 CACNA1C RBFOX3 PCLO AFF3 MICAL2 CNTNAP2 ATP2B1	2.60e-07	200	256	10	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CEACAM6 NR6A1 MAST4 STK39 MLPH SFTPB TACC2 GRIP1 TMC5	4.30e-07	162	256	9	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXK2 REC114 TONSL CDT1 FLT4 KIAA1549 SHROOM1 ARHGAP28 BMP15	5.56e-07	167	256	9	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	C5orf67 BRINP1 MAST4 SLC39A5 KIAA1549 ADORA2A-AS1 KIAA1755 MAP3K13 ALPK2	9.93e-07	179	256	9	d1ef7e1cb00336118e387b47f4f8120f53584391
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	FREM2 MAST4 SVIL SDC4 PARM1 SFTPB TACC2 GRIP1 TMC5	1.09e-06	181	256	9	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	normal-na-Lymphocytic_B-B_mem-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HLA-DPA1 SYNPO UTY UBE2J1 PCDHGA6 COBLL1 AFF3 POU2F2 ATP2B1	1.14e-06	182	256	9	ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	CEACAM6 KCNC2 MLPH SDC4 CACNA1C SFTPB LAMA2 TACC2 TMC5	1.19e-06	183	256	9	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	FREM2 MAST4 PARM1 SFTPB AFF3 TACC2 CCDC141 FHDC1 TMC5	1.19e-06	183	256	9	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L NR6A1 MAST4 TOX3 PARM1 SFTPB AFF3 GRIP1 MAP3K13	1.31e-06	185	256	9	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	KCNH6 TOX3 MAP4K4 SLC39A5 PARD3B LRP1 KIAA1755 GREB1 PPP6R2	1.31e-06	185	256	9	1d874608aa2062024323512f68889219471b2f00
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SECISBP2L NR6A1 FREM2 MAST4 STK39 MLPH SFTPB LRBA TMC5	1.37e-06	186	256	9	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	C5orf67 BRINP1 KCNH6 MAST4 PLIN4 KIAA1671 KIAA1755 MAP3K13 ALPK2	1.37e-06	186	256	9	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	TNIK FREM2 MAST4 PARM1 SFTPB EML4 AFF3 CCDC141 FHDC1	1.43e-06	187	256	9	030af361f8bdcd0aff4ec1922702833325cf74d8
Disease	prostate carcinoma	SP3 C5orf67 HLA-DPA1 ETV3 ZNF236 EMSY TASOR2 SENP1 MAST4 STK39 ADGRL2 MLPH MAML3 PHIP LILRA5 POU2F2 C6orf15 POLI KIF13A SPEN	4.07e-05	891	238	20	EFO_0001663
Disease	MEHMO syndrome (implicated_via_orthology)	EIF2S3B EIF2S3	6.48e-05	2	238	2	DOID:0060801 (implicated_via_orthology)
Disease	glucose metabolism disease (implicated_via_orthology)	KCNH6 IRS4 EIF2S3B EIF2S3	7.26e-05	28	238	4	DOID:4194 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in large VLDL percentage	PDXDC1 ANKRD31 C5orf67 COBLL1 NFE2L3	8.94e-05	56	238	5	EFO_0022250
Disease	free cholesterol to total lipids in medium VLDL percentage	PDXDC1 ANKRD31 C5orf67 COBLL1 NFE2L3	9.74e-05	57	238	5	EFO_0022284
Disease	HDL cholesterol change measurement, physical activity	EDC4 LILRA5 COBLL1 RBM6 RBM5	1.46e-04	62	238	5	EFO_0003940, EFO_0007805
Disease	triglycerides to total lipids in medium VLDL percentage	PDXDC1 ANKRD31 C5orf67 COBLL1 NFE2L3	1.57e-04	63	238	5	EFO_0022335
Disease	Kabuki syndrome (implicated_via_orthology)	KDM6A UTY	1.93e-04	3	238	2	DOID:0060473 (implicated_via_orthology)
Disease	Cryptophthalmos syndrome	FREM2 GRIP1	1.93e-04	3	238	2	C0265233
Disease	Joint Instability	ZNF469 COMP	1.93e-04	3	238	2	C0022410
Disease	Joint laxity	ZNF469 COMP	1.93e-04	3	238	2	C0086437
Disease	FRASER SYNDROME 1	FREM2 GRIP1	1.93e-04	3	238	2	C4551480
Disease	nasopharyngeal neoplasm	ETV3 FLT4 PCLO PRPF38B C6orf15 CNTNAP2 IRAG2	2.34e-04	151	238	7	EFO_0004252
Disease	cortical surface area measurement	TNIK ATXN2L C5orf67 RIN3 STOX1 ELAC2 ZNF469 MAST4 TOX3 PKD1 ADGRL2 MAP4K4 TANGO6 LIN28B LAMA2 TRIOBP PARD3B NR2F2 SIAH3 GRIP1 C6orf15 KIAA1755 ARHGAP28 PLEKHM3	2.46e-04	1345	238	24	EFO_0010736
Disease	Congenital small ears	FREM2 CDT1 KDM6A GRIP1	3.31e-04	41	238	4	C0152423
Disease	free cholesterol to total lipids in small VLDL percentage	PDXDC1 ANKRD31 C5orf67 COBLL1 NFE2L3	3.57e-04	75	238	5	EFO_0022287
Disease	Fraser syndrome (implicated_via_orthology)	FREM2 GRIP1	3.85e-04	4	238	2	DOID:0090001 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	TNIK SP3 C5orf67 C16orf90 EMSY SVIL PKD1 ADGRL2 ATRN SFTPB EML4 COBLL1 TRIOBP NFE2L3 ADORA2A-AS1 LRBA PPP6R2 ALPK2	4.84e-04	914	238	18	EFO_0004532
Disease	cardiac troponin I measurement	POU6F2 SYNPO2 ELAC2 CRYBG1 PARD3B CNTNAP2 GREB1	5.90e-04	176	238	7	EFO_0010071
Disease	interleukin-2 receptor subunit alpha measurement	NET1 TASOR2 PRPF38B	6.19e-04	21	238	3	EFO_0010587
Disease	adenoid cystic carcinoma (is_implicated_in)	KMT2C KDM6A	6.38e-04	5	238	2	DOID:0080202 (is_implicated_in)
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	PDXDC1 ANKRD31 C5orf67 LILRA5 COBLL1	6.70e-04	86	238	5	EFO_0008595, EFO_0020945
Disease	cortical thickness	TNIK C5orf67 RIN3 STOX1 ELAC2 ZNF469 MAST4 SMG7 TOX3 PKD1 CAMTA1 LAMA2 TRIOBP TACC2 NR2F2 GRIP1 LRP1 KIAA1755 LSM14A KIF13A	7.48e-04	1113	238	20	EFO_0004840
Disease	Sarcosine measurement	PCDHGB1 PCDHGA7 PCDHGA6	8.14e-04	23	238	3	EFO_0021668
Disease	lifestyle measurement, anxiety disorder measurement	FOXK2 BRINP1 KCNC2 PPP2R2C RBM6 LRBA	8.82e-04	137	238	6	EFO_0007795, EFO_0010724
Disease	triglycerides to total lipids in very large VLDL percentage	PDXDC1 ANKRD31 C5orf67 COBLL1	8.86e-04	53	238	4	EFO_0022340
Disease	free cholesterol to total lipids in small LDL percentage	PDXDC1 C5orf67 DCT COBLL1	8.86e-04	53	238	4	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	PDXDC1 C5orf67 COBLL1 NFE2L3	8.86e-04	53	238	4	EFO_0022258
Disease	hypertrophic cardiomyopathy	FADS2B KMT2C PKD1 PARD3B CCDC141	9.10e-04	92	238	5	EFO_0000538
Disease	body fat percentage, fasting blood insulin measurement	C5orf67 COBLL1	9.51e-04	6	238	2	EFO_0004466, EFO_0007800
Disease	hypopituitarism (implicated_via_orthology)	EIF2S3B EIF2S3	9.51e-04	6	238	2	DOID:9406 (implicated_via_orthology)
Disease	cholesterol to total lipids in very large VLDL percentage	PDXDC1 C5orf67 COBLL1 NFE2L3	9.51e-04	54	238	4	EFO_0022244
Disease	Metastatic melanoma	TTBK1 FLT4 MAP3K13 ALPK2	9.51e-04	54	238	4	C0278883
Disease	mental development measurement	PCDHGB1 PCDHGA7 PCDHGA6	1.05e-03	25	238	3	EFO_0008230
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	PDXDC1 C5orf67 DCT COBLL1	1.09e-03	56	238	4	EFO_0022316
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	PDXDC1 ANKRD31 C5orf67 LILRA5 COBLL1 NFE2L3	1.14e-03	144	238	6	EFO_0004611, EFO_0020943
Disease	triglycerides to total lipids in small VLDL percentage	PDXDC1 ANKRD31 C5orf67 NFE2L3	1.24e-03	58	238	4	EFO_0022338
Disease	cholesterol to total lipids in medium LDL percentage	PDXDC1 ANKRD31 LILRA5	1.31e-03	27	238	3	EFO_0022238
Disease	grapefruit juice consumption measurement	CACNA1C PCLO	1.32e-03	7	238	2	EFO_0010094
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	PDXDC1 C5orf67 DCT COBLL1	1.33e-03	59	238	4	EFO_0022260
Disease	resting heart rate	REC114 SPEG CACNA1C CCDC141 MICAL2 KIAA1755	1.36e-03	149	238	6	EFO_0004351
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	PDXDC1 ANKRD31 C5orf67 COBLL1 NFE2L3 LRBA	1.41e-03	150	238	6	EFO_0004611, EFO_0020947
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	PDXDC1 C5orf67 DCT COBLL1	1.41e-03	60	238	4	EFO_0021898
Disease	Antihypertensive use measurement	CASZ1 HOXC4 PHIP CACNA1C CCDC141 RBM6 LRBA ATP2B1	1.47e-03	265	238	8	EFO_0009927
Disease	total lipids in chylomicrons and extremely large VLDL measurement	PDXDC1 C5orf67 DCT COBLL1	1.60e-03	62	238	4	EFO_0022306
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	PDXDC1 C5orf67 DCT COBLL1	1.60e-03	62	238	4	EFO_0022263
Disease	glucagon measurement	TNIK ETV3 ZNF469 ADGRL2 UBE2J1 ADORA2A-AS1	1.61e-03	154	238	6	EFO_0008463
Disease	cholesterol to total lipids in medium VLDL percentage	PDXDC1 ANKRD31 C5orf67 COBLL1	1.69e-03	63	238	4	EFO_0022239
Disease	free cholesterol to total lipids in medium LDL percentage	PDXDC1 C5orf67 DCT COBLL1	1.69e-03	63	238	4	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	PDXDC1 C5orf67 DCT COBLL1	1.69e-03	63	238	4	EFO_0022292
Disease	Sudden Cardiac Death	PPP1R13L CACNA1C	1.76e-03	8	238	2	C0085298
Disease	brain measurement, neuroimaging measurement	PDXDC1 TNIK ATXN2L C5orf67 RIN3 ELAC2 MAST4 TOX3 TANGO6 TRIOBP LATS1 KIAA1755	1.82e-03	550	238	12	EFO_0004346, EFO_0004464
Disease	Benign Neoplasm	SRF KDM6A LIN28B NACC1	2.24e-03	68	238	4	C0086692
Disease	Neoplasms	SRF KDM6A LIN28B NACC1	2.24e-03	68	238	4	C0027651
Disease	leukodystrophy (implicated_via_orthology)	EIF2S3B EIF2S3	2.25e-03	9	238	2	DOID:10579 (implicated_via_orthology)
Disease	3-hydroxypropylmercapturic acid measurement	TNIK FOXK2 TOPAZ1 EMSY USP31 RBFOX3 PWWP2B CNTNAP2 ARHGAP28	2.36e-03	352	238	9	EFO_0007014
Disease	rheumatoid arthritis, celiac disease	PTPRC SMG7 AFF3	2.36e-03	33	238	3	EFO_0000685, EFO_0001060
Disease	cognitive function measurement, self reported educational attainment	NEK4 FAM120A ZC3H7B MAML3 MRTFA AFF3 TRIOBP C6orf15 RBM5	2.50e-03	355	238	9	EFO_0004784, EFO_0008354
Disease	phospholipids:total lipids ratio	PDXDC1 ANKRD31 C5orf67 DCT LILRA5 COBLL1 NFE2L3	2.55e-03	227	238	7	EFO_0020946
Disease	estrogen-receptor negative breast cancer	C5orf67 RIN3 MRTFA USHBP1	2.63e-03	71	238	4	EFO_1000650
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB1 PCDHGA7 PCDHGA6 PCDHGA12	2.63e-03	71	238	4	EFO_0007878, EFO_0007979
Disease	neuroimaging measurement	SECISBP2L PDXDC1 TNIK ATXN2L C5orf67 ELAC2 NEK4 ZNF469 MAST4 TOX3 PKD1 CAMTA1 AFF3 LAMA2 TACC2 NR2F2 KIAA1755 TMC5	2.76e-03	1069	238	18	EFO_0004346
Disease	waist-hip ratio, high density lipoprotein cholesterol measurement	C5orf67 C6orf15	2.79e-03	10	238	2	EFO_0004343, EFO_0004612
Disease	glomerular filtration rate, renal transplant outcome measurement	TNIK ADGRL2 MICAL2	2.80e-03	35	238	3	EFO_0005199, EFO_0005208
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ATXN2L POU6F2 RIN3 HOXC4 CAMTA1 MAML3 COBLL1 PARD3B LRP1	2.95e-03	364	238	9	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	fatty acid measurement	PDXDC1 ANKRD31 C5orf67 NEK4 CAMTA1 RAD9A FAM13C COBLL1 NFE2L3 PPP6R2	3.02e-03	436	238	10	EFO_0005110
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CACNA1C DRP2 EML4	3.04e-03	36	238	3	DOID:11723 (implicated_via_orthology)
Disease	juvenile idiopathic arthritis	NPHP4 AFF3 LAMA2 FAS	3.05e-03	74	238	4	EFO_0002609
Disease	neuroticism measurement	POU6F2 HLA-DPA1 BRINP1 ZCCHC14 FAM120A KCNC2 TOX3 CAMTA1 ZC3H7B LIN28B PCLO PWWP2B MICAL2 ASXL3 C6orf15 POLI	3.06e-03	909	238	16	EFO_0007660
Disease	diastolic blood pressure, systolic blood pressure	REC114 HLA-DPA1 SPEG CASZ1 SVIL TANGO6 CACNA1C FAM13C KIAA1671 USHBP1 C6orf15 LRP1 DCP1A	3.29e-03	670	238	13	EFO_0006335, EFO_0006336
Disease	household income	BRINP1 MAST4 MAML3 NACC1 AFF3 ZSWIM6 RBM6 CTNND1	3.42e-03	304	238	8	EFO_0009695
Disease	breast carcinoma	C5orf67 RIN3 FOXK2 CASZ1 LAX1 TASOR2 TTBK1 TOX3 IRF2BPL ZC3H7B PHIP MRTFA ARHGEF5 TACC2 USHBP1 EXO1 GREB1	3.94e-03	1019	238	17	EFO_0000305
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN2L PPP2R2C	4.05e-03	12	238	2	DOID:1441 (implicated_via_orthology)
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	NR2F2 LRP1	4.05e-03	12	238	2	DOID:3827 (implicated_via_orthology)
Disease	right ventricular stroke volume measurement	CCDC141 KIAA1755	4.05e-03	12	238	2	EFO_0021817
Disease	extrapulmonary tuberculosis	ZBTB5 CACNA1C	4.05e-03	12	238	2	MONDO_0000368
Disease	electrocardiography	ATXN2L HLA-DPA1 SPEG CASZ1 MAST4 SVIL CACNA1C CCDC141 CNTNAP2 RBM6 KIAA1755	4.06e-03	530	238	11	EFO_0004327
Disease	ovarian carcinoma	TNIK SYNPO2 TONSL PARD3B TACC2 USHBP1 ASXL3 CTNND1	4.73e-03	321	238	8	EFO_0001075
Disease	sphingomyelin 18:1 measurement	CACNA1C PARD3B	4.77e-03	13	238	2	EFO_0010394
Disease	Connective Tissue Diseases	ZNF469 PKD1	4.77e-03	13	238	2	C0009782
Disease	fibromuscular dysplasia	SVIL LRP1 ATP2B1	5.38e-03	44	238	3	EFO_1000938
Disease	reticulocyte measurement	C5orf67 FOXK2 USP9X ZNF469 SENP1 PTPRC AFDN CDT1 ATRN COBLL1 AFF3 MICAL2 RBM6 LSM14A FHDC1 CTNND1 ATP2B1	5.44e-03	1053	238	17	EFO_0010700
Disease	beta-amyloid 1-42 measurement	TNIK TRPV2 RBFOX3 RNF111	5.45e-03	87	238	4	EFO_0004670
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 LATS1	5.53e-03	14	238	2	DOID:898 (implicated_via_orthology)
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	CNTNAP2 RNF111	5.53e-03	14	238	2	OBA_2045142
Disease	esophagus squamous cell carcinoma (is_implicated_in)	KMT2C KDM6A SPEN	5.73e-03	45	238	3	DOID:3748 (is_implicated_in)
Disease	alcohol consumption measurement	SECISBP2L ATXN2L POU6F2 TOPAZ1 NR6A1 MAST4 KCNC2 CAMTA1 ZC3H7B ADGRL2 TANGO6 CACNA1C COBLL1 PCLO AFF3 POU2F2 PAPLN GRIP1 ADORA2A-AS1	5.94e-03	1242	238	19	EFO_0007878
Disease	susceptibility to plantar warts measurement	HLA-DPA1 CAMTA1 C6orf15 CNTNAP2	6.14e-03	90	238	4	EFO_0008406
Disease	cognitive function measurement	ATXN2L POU6F2 SYNPO2 BRINP1 ZCCHC14 MAST4 FAM120A KCNC2 CRYBG1 MAML3 MRTFA CACNA1C RBFOX3 AFF3 TRIOBP PARD3B ZSWIM6 NR2F2 TTLL2 RBM6 FHDC1	6.34e-03	1434	238	21	EFO_0008354
Disease	Non-steroidal anti-inflammatory and antirheumatic product use measurement	SYNPO MAML3	6.35e-03	15	238	2	EFO_0009935
Disease	Gastro-enteropancreatic neuroendocrine tumor	PTPRC POU2F2	6.35e-03	15	238	2	C2930967
Disease	Sclerocystic Ovaries	EMSY TONSL FLT4 PWWP2B BMP15	6.36e-03	144	238	5	C1136382
Disease	Polycystic Ovary Syndrome	EMSY TONSL FLT4 PWWP2B BMP15	6.36e-03	144	238	5	C0032460
Disease	systolic blood pressure, alcohol consumption measurement	CASZ1 HOXC4 ATP2B1	6.47e-03	47	238	3	EFO_0006335, EFO_0007878
Disease	myopia (is_implicated_in)	SLC39A5 LAMA2	7.22e-03	16	238	2	DOID:11830 (is_implicated_in)
Disease	central nervous system disease (implicated_via_orthology)	IRF2BPL SEC31A	7.22e-03	16	238	2	DOID:331 (implicated_via_orthology)
Disease	lower body strength measurement	RBFOX3 KIAA1671	7.22e-03	16	238	2	EFO_0007999
Disease	comparative body size at age 10, self-reported	C5orf67 BRINP1 TTBK1 MAST4 FAM120A CAMTA1 ZC3H7B RAD9A ZSWIM6	7.38e-03	420	238	9	EFO_0009819
Disease	peak expiratory flow	ZCCHC14 SENP1 SVIL PKD1 MRTFA EML4 ZSWIM6 NCMAP LRP1 PPP6R2	7.54e-03	498	238	10	EFO_0009718
Disease	polyunsaturated fatty acids to total fatty acids percentage	PDXDC1 C5orf67 COBLL1	7.68e-03	50	238	3	EFO_0022303

Protein segments in the cluster

Peptide	Gene	Start	Entry
NVSSPVNLGNPEEHT	UXS1	316	Q8NBZ7
PGNGAPDVFQTLQHT	USHBP1	111	Q8N6Y0
TPHAAFQPNSQIGEE	ACIN1	116	Q9UKV3
NRADHRSSPNVANQP	AFDN	1166	P55196
AGHPPSDGQQRATQQ	AFF3	151	P51826
LANTANPRGDTSHSP	CTTNBP2NL	536	Q9P2B4
LHEVSLSGQNEAPPN	EOGT	11	Q5NDL2
FQREPESKNAPHSQG	PPP2R2C	51	Q9Y2T4
SRAQVPGHQPEATNL	ADCK2	291	Q7Z695
GPQSDVLSPQDHHQQ	AMOT	56	Q4VCS5
DPLSHPGAEQTGIQN	CDY2A	186	Q9Y6F7
LNTVPPIEDDHGNSN	CAMTA1	31	Q9Y6Y1
SHTGAPVQQAASPTN	ANKRD13D	311	Q6ZTN6
NPLDHQITNERGEPS	CTAGE4	566	Q8IX94
NPLDHQITNERGEPS	CTAGE6	566	Q86UF2
NPLDHQITNERGEPS	CTAGE8	566	P0CG41
NPLDHQITNERGEPS	CTAGE9	566	A4FU28
NPLDHQITNERGEPS	CTAGE15	566	A4D2H0
INPAQSGSPNHVDSA	C9orf129	86	Q5T035
HGPAQQLTFPTEQAA	C9orf129	166	Q5T035
QPSHQEPAGTDQHVS	BRINP1	21	O60477
LASTVHAGQEQPSPS	ALPK2	921	Q86TB3
KEPSNESNGHAVPAN	CASZ1	936	Q86V15
PPANSTGTVQHLRSD	ARHGEF5	591	Q12774
HQDSRDNCPTVPNSA	COMP	441	P49747
DRHPTQGDQEAPVSQ	CT47B1	6	P0C2W7
DTHSPTNDVQPGRFS	ETV3	156	P41162
HTDPNFPSNSNAVGT	ADORA2A-AS1	36	P86434
SHLQPGQLSAPAQSR	BARHL1	76	Q9BZE3
EEQGPADHPSRLNQA	CEP41	316	Q9BYV8
GQPPHLTSAQDQDTI	CDT1	106	Q9H211
QRSNHTQATNDPPEV	HLA-DPA1	106	P20036
PPAETANGTSEQHVR	CPXM1	51	Q96SM3
SAPVFNSPGHSLNNA	ADGRL2	1201	O95490
ISQENAPGPAHNGRE	CEACAM7	86	Q14002
QSPSQANGCSDHRPI	DCP1A	141	Q9NPI6
AHNEQNSQIPTPTDG	COBLL1	1046	Q53SF7
PSPNKNNNAVDSGIH	ATP2B1	1181	P20020
EPTAPSHNFAEQARG	ASXL3	1571	Q9C0F0
SQHAAPSPVQHQAGQ	ATXN2L	886	Q8WWM7
PSDVQNGHLDPNSDC	ARHGEF9	76	O43307
TAGNAHKNSENEPPN	CPXCR1	11	Q8N123
NGDESSDPGPQHRAQ	P4HTM	86	Q9NXG6
APRLSSGNHPQSNSE	MROH7	136	Q68CQ1
GPGHSNTQEKQPATV	RAVER2	501	Q9HCJ3
SVPRQPGSHQHSEQQ	REC114	176	Q7Z4M0
QVADTNDNPPTFPHS	PCDHGA7	441	Q9Y5G6
QLQAHSTPHPDDFAN	RAD9A	286	Q99638
AQTHPEQPGSEASTQ	RBFOX3	51	A6NFN3
PTQPTHGQFALTNGD	NR2F2	156	P24468
GTPVPSAHLDCQAQQ	EDC4	1251	Q6P2E9
THISLNVADTNDNPP	PCDHGA12	436	O60330
GPQPESHQQLSASSH	KCNK6	291	Q9Y257
SELHSNSALPGPVDN	KIAA1549	391	Q9HCM3
HDPSPAQSHTLQAND	NET1	471	Q7Z628
PSFDHSNGNPEQNSL	ANKRD31	996	Q8N7Z5
DRHPTQGDQEAPVSQ	CT47A1	6	Q5JQC4
APNPPSAQAHQLAAA	FHDC1	611	Q9C0D6
QLAAAQPENHASAFP	FHDC1	621	Q9C0D6
AKQRNPETETHGPQN	MUC16	2101	Q8WXI7
HKIESPSGNPADRQS	PARD3B	86	Q8TEW8
GNSESVHPALQRPAE	MAP4K4	606	O95819
GPDVQPSHQLRASGA	INKA1	41	Q96EL1
NVADTNDNPPTFPHS	PCDHGA6	441	Q9Y5G7
VGAQPNDPSASEHTQ	KCNC2	406	Q96PR1
HPSAQLQPVGGDAVS	LILRA5	6	A6NI73
TDSHAEQGPAQQPQA	MDN1	5126	Q9NU22
SQTAHDVADQPRPGS	KMT2C	2316	Q8NEZ4
TNGPSDSQARTHPDA	KIAA1671	891	Q9BY89
NQHTRNRQGQSSDPP	NGLY1	146	Q96IV0
SITHNQAQGPRQPAS	MAML3	891	Q96JK9
SAQPTALPQGEHARS	GREB1	1146	Q4ZG55
QAQSHGEARLSDPPG	MEPCE	91	Q7L2J0
HSESPNSQTDVGRPL	LATS1	201	O95835
PTAVHGQVNNAAASP	FOXK2	586	Q01167
SASLPTKRHNGDQPE	FOXK2	611	Q01167
ELHQASSPDNQVLPA	KIAA1755	216	Q5JYT7
ETHANCTNQATRPPG	LRP1	1046	Q07954
PGENLNLSCHAASNP	CEACAM6	251	P40199
NPLNGSVCERPANHS	ATRN	911	O75882
TQRPSDNSHNEHAPA	LAIR1	141	Q6GTX8
TFRVQDNHDPPNQSG	FREM2	671	Q5SZK8
LNADDPTAGHSNAPI	CSNK1G2	371	P78368
ETPNSTASVEGLPNH	KDM6A	736	O15550
LHSSPRQAPGSQDHQ	KCNH6	721	Q9H252
HKNVAQPPASSQGRQ	LIN28B	166	Q6ZN17
VQKNPTNHFPSSEGD	BMP15	156	O95972
PTNSAQQGHNSPDSP	DDX42	741	Q86XP3
QQGHNSPDSPVTSAA	DDX42	746	Q86XP3
SQHESEQDFSQGPCP	KCNV1	176	Q6PIU1
HSNRTTPPESAPQNG	IRF2BPL	606	Q9H1B7
QASNLISTAGQPGPH	PCLO	941	Q9Y6V0
PAAAPATGNRNTHLV	OGDHL	976	Q9ULD0
HVSENNPPGASIAQV	PCDHGB1	456	Q9Y5G3
PSPQHTDQTEAFQKG	PDXDC1	756	Q6P996
LQPHNSGSEPSLSRQ	NEK4	521	P51957
NSHTTNPEQTLPGTN	NFE2L3	346	Q9Y4A8
TDTERNGPDTNHQNP	POU2F2	31	P09086
SRNSESPEHVPSQAG	LAX1	121	Q8IWV1
SPEHVPSQAGNAFQE	LAX1	126	Q8IWV1
PRDFTNISQGSNPHC	PRKD3	471	O94806
SNSPVTHVAANTQPG	LRBA	2516	P50851
THVAANTQPGLATPA	LRBA	2521	P50851
PAANRTPGEAHNETL	LINGO3	501	P0C6S8
EQAVQTASAHLPAPA	LSM14A	196	Q8ND56
AASSSRNLEPHGKQP	METTL18	81	O95568
EQLTDHHPQTNPSVG	GOLGA6L22	16	H0YM25
SNPNQRHPITNAIDG	LAMA2	91	P24043
DHPSNTVPSGSNQDL	KLK5	36	Q9Y337
PINPAQSGSPNHVDS	FAM120A	436	Q9NZB2
PSNGTHNNSVLPVTA	PARM1	56	Q6UWI2
PSPNKIEDAQGNTEH	PLEKHM3	191	Q6ZWE6
PRPASTHNGSVDTEN	GPR78	341	Q96P69
DQGQRSAAAPHPAPD	IQSEC3	96	Q9UPP2
VPAAESSSHQQSGLP	RBM5	506	P52756
SQVGEDSLSHQPDPA	PIGK	226	Q92643
PNATSLHVPHSQEGN	GPR75	11	O95800
AVGPNSNGSQHPATV	NCMAP	76	Q5T1S8
LPHGSQASPAQAQEF	NPHP4	526	O75161
LAPGEPSQERHKNSQ	FADS2B	131	A8MWK0
SPLSNHAQRQLPGSS	MAP3K13	681	O43283
QSQLASGATRAHPPT	MYO15B	621	Q96JP2
PQQNPSSTHGPAERS	SMPD2	286	O60906
EGNANSPAHLRGPEQ	BOD1L1	2496	Q8NFC6
SNSEHPQPALDPRSN	C6orf15	56	Q6UXA7
SSEKHIQRQGSEPNP	FRG2B	51	Q96QU4
SSEKHIQRQGSEPNP	FRG2	51	Q64ET8
QNRKSGSAAPHQLPD	SLC37A1	66	P57057
EGPNVNPELTQGAHS	CCDC141	201	Q6ZP82
NANAAAGLAPEHIPT	CACNA1C	31	Q13936
QGQEHPGLNVSSPFS	C5orf67	86	F2Z3F1
QHQLGAEVSSSPRAP	FRMPD3	1056	Q5JV73
HSQSATPPEQQRAED	HOXC4	246	P09017
ETHPGAQSSPANFRI	PYHIN1	456	Q6K0P9
DQLPSPNAVSSDQVH	ADGRF2	66	Q8IZF7
EFQDSSAPPAQSPQH	AKNA	261	Q7Z591
DAVSQAQGRPGHPDA	C16orf90	16	A8MZG2
SNPVASGNHLQPSEV	MS4A18	26	Q3C1V0
SPANHENQPSEGERI	MARF1	1571	Q9Y4F3
SAHAGNSPQDSPRNF	MAST4	251	O15021
SNPQQREGSSPKHQD	MAST4	1916	O15021
SVLNHSNQEPGRGPS	ITIH6	371	Q6UXX5
SPTIEAQGTSPAHDN	IRAG2	131	Q12912
HVQNGDSPSLAPQTT	GPR156	636	Q8NFN8
SRVDNAPDQQNSHPD	CNTNAP2	1031	Q9UHC6
NAAIQHNASLPVPAE	EMSY	121	Q7Z589
ESHSNDQSPQIRASP	EML4	131	Q9HC35
GNESCPQPQTSEHLA	EIF2S3B	161	Q2VIR3
DSLGNEHNPFSQPVH	CRYBG1	251	Q9Y4K1
GNHLATPQRPDQTVT	CRYBG1	656	Q9Y4K1
VPHQALGRTQSSPAA	HDAC5	651	Q9UQL6
QQPSHGGNLETREPT	GRIP1	1111	Q9Y3R0
TSPNQQPDTNLAHVG	CEP295	2141	Q9C0D2
SSQGVHDQVLPTPNA	POLI	36	Q9UNA4
QVDESPVNDSHGRAP	PWWP2B	56	Q6NUJ5
NHPARSSGQSPDVGN	RSC1A1	11	Q92681
DNHIPERAGSGSQVP	SDC4	86	P31431
SASSEPRPEGHNNPQ	SALL2	76	Q9Y467
NDPSQPNEEGITALH	PPP1R13L	651	Q8WUF5
QEAAPNVANNTGPHA	CTNND1	601	O60716
CQDASRAHPGDPNAQ	DCAF15	196	Q66K64
NKNRPEPHSDENGST	CEBPZ	141	Q03701
LASSPQQSEGSHPRE	DRP2	891	Q13474
ANPEGHSASSDQDPV	GARNL3	971	Q5VVW2
HQTNRQEKSPQDPGD	MLPH	436	Q9BV36
HENGNRSLETPQPAA	PPP6R2	421	O75170
DQHSPGRNQSSAFSP	MICAL2	1586	O94851
GSPVLTQSQPAANHT	PKD1	1166	P98161
DTGVHSQTHTQAPPQ	PRR14L	1781	Q5THK1
SQAGTQHPPAQATAH	RIN3	506	Q8TB24
NPGAHNPSANLARGD	IRS4	1186	O14654
PNVHNVSSSRPDLSG	KIF13A	1386	Q9H1H9
DHSSPGNRASESNQP	NR6A1	176	Q15406
APALSVSPQNNHSPD	KIF13B	1426	Q9NQT8
AAEAAQPQAQVAAHP	PLIN4	41	Q96Q06
GEAPQNLSQTQRSPH	USP9X	581	Q93008
SLPTNSVSNRQPHGA	UTY	481	O14607
DAVSSPNHGDSPNLL	UTY	706	O14607
HESPADFQNSQSPVQ	RBM6	351	P78332
QAPASANLVGPRSAH	SRRM2	2331	Q9UQ35
QARPGPHTQDLSEQQ	SFTPB	186	P07988
SEPVSQDAKPTGHNR	SVIL	521	O95425
QAQTLGQDSLGPPEH	SYNE4	46	Q8N205
VHSPAADVNQNLASP	SYNPO	306	Q8N3V7
NSKSPESDNHDPGQL	SAMD9L	76	Q8IVG5
LSDPGTPDQHQASQT	POU6F2	71	P78424
EENQDSSGHFSNIPP	GCM2	196	O75603
LQPTAHSPAGNQVQA	SMG7	696	Q92540
AQREHRQNTASPGSP	PSD4	121	Q8NDX1
RQNTASPGSPVNSHL	PSD4	126	Q8NDX1
SPASSQEGSPQLQHH	PSD4	461	Q8NDX1
HSVPHQPDNLAASNT	SENP1	296	Q9P0U3
QEQHSEGRSAPSSEP	SIN3B	636	O75182
RAVTQSAPEQGSFHP	SIAH3	51	Q8IW03
HASQGPPASVHASDQ	SHROOM1	406	Q2M3G4
SEGHQNCEFSQPPES	SHROOM4	336	Q9ULL8
PQHSALEDSSLAPGN	SHROOM4	941	Q9ULL8
SPKHSNNQPAAGALR	SECISBP2L	276	Q93073
QVRAGTPAHESPQNN	FAM13C	121	Q8NE31
QGSQQPSLADPASHL	FAM13C	456	Q8NE31
GNAVHQPSGLTSQPQ	RIPK1	446	Q13546
ARNSSDDIPNNHIPG	EXO1	556	Q9UQ84
DALSPEQPASHESQG	MRTFA	121	Q969V6
ATPVNGHSPALQSQS	TRIOBP	1636	Q9H2D6
QVHQAPQQASPSRDS	SRF	361	P11831
ASPAADNSTHRPQNP	SLC39A5	86	Q6ZMH5
DNSTHRPQNPELSVD	SLC39A5	91	Q6ZMH5
ADSQEPSHFDSQQPA	SLC39A6	496	Q13433
PQHAEVNGNTSTPSA	SPART	136	Q8N0X7
QGPALTASQSVHEQP	TNIK	601	Q9UKE5
HNGDVTGSSRPQSQP	ZBTB21	816	Q9ULJ3
SALNSSQNGEEQPAP	ZBTB5	156	O15062
QQPASRSHGAAPALD	TTBK1	1171	Q5TCY1
ESNENEPHLPHGVSQ	ELAC2	216	Q9BQ52
DTVQAHAARAQSPTP	SYNPO2	891	Q9UMS6
ENSGPSHDPSQNETL	TCEANC	101	Q8N8B7
HAENPDSQAVPSAAG	MPDZ	1561	O75970
SPAANEGTTVQHPEA	SPEN	2366	Q96T58
PPRHNAAQINGKTES	PHIP	1486	Q8WWQ0
ASENHQNNPAVPSGS	RNF111	281	Q6ZNA4
LPHNQLAAQAGATTP	SPEG	2506	Q15772
NQGSHESPTLNPETV	FAS	206	P25445
SPAGEQEPSQHRTGA	PAPLN	831	O95428
AQHPEGPQSREGATS	ST20-AS1	46	Q8NBB2
SQQEDSGQHAAPLPA	TOM1	186	O60784
HATPGESQEPNLSAE	STOX1	806	Q6ZVD7
SAGIQLHPGENADSP	SP3	531	Q02447
ASQAHVRVSPGQAAP	TONSL	711	Q96HA7
PRRHGPASAANANNA	VSTM2B	171	A6NLU5
PPRDTCGNHTNQLDG	ARHGAP28	181	Q9P2N2
PALTGNSQPQHQAAA	PRPF38B	6	Q5VTL8
VASPETQLGNHDRNP	ZSCAN5B	26	A6NJL1
GPGQNVAVTRAHPDS	FLT4	1301	P35916
NPHQPASLQATDSQG	TRPV2	231	Q9Y5S1
HETAPQTGLQSNAPI	TANGO6	801	Q9C0B7
STSPDVIQGHQPRDN	UBE2J1	266	Q9Y385
HSNRNSDSAGPFAVP	TTC3	1056	P53804
PSAQSPGVHADADQV	PHC1	191	P78364
NSSNSVVPVSNPAHG	USF3	1381	Q68DE3
QVPNDNSGPDQHTLS	USF3	2046	Q68DE3
APSPQERGEHLNTEQ	TACC2	491	O95359
TAALHGDSPARPQQA	TACC2	1761	O95359
TQLPFQEQDSSPGAH	TECPR2	611	O15040
SEANHTEQPPAGLGA	TTLL2	31	Q9BWV7
AIGSPQPASQQHQSQ	TOX3	546	O15405
LNGTNALPHSAANDP	DCT	376	P40126
DNSQHPQPADSRQTG	TOP3A	776	Q13472
SNHAPVTQAREGNLP	VASN	561	Q6EMK4
QSHRNASHQTPQGDP	ZNF469	2396	Q96JG9
KPSNHVSEPGNIVSN	TOPAZ1	781	Q8N9V7
VLPVQNEASSNPSGH	ZCCHC14	476	Q8WYQ9
QNSEINQVHGAPDPT	ZSWIM6	336	Q9HCJ5
PVNGAHPTLQADDDS	SLC30A4	61	O14863
HSASPSPRGALEDQQ	SLC46A2	56	Q9BY10
PSAGQHVQERFSPNS	ZNF212	396	Q9UDV6
APHAQNPDVSSVSNE	ZNF236	421	Q9UL36
PENTTAAHNDLPENS	TASOR2	511	Q5VWN6
AQSNSDHPGPRANLN	TMC5	166	Q6UXY8
AERGHQPPASQQPNA	USP31	1271	Q70CQ4
SQHADLPEQAAARSP	TCHHL1	301	Q5QJ38
CAQNNHAPSDTIPES	ZSWIM1	301	Q9BR11
DLQGPEQSPNDAHRG	ZNF629	11	Q9UEG4
HGNVNPNAAGQLPTS	SEC31A	846	O94979
IQSLSVHDSQGPPNA	STK39	426	Q9UEW8
EHSVNGPASPALNQG	PTPRC	1291	P08575
NRESPGQAEINPVHS	ZSCAN5C	321	A6NGD5
LSILDRSPGHQNNPA	TGM6	191	O95932
RSPGHQNNPATDVSC	TGM6	196	O95932
APQSEPREGSHNAQE	ZNF467	21	Q7Z7K2
FHAELAPPQGQGQAT	TEX13B	151	Q9BXU2
DAAAPAEPQAQHTRS	WFS1	56	O76024
ETNSQDHRPPSGAQK	ZC3H7B	381	Q9UGR2
GNESCPQPQTSEHLA	EIF2S3	161	P41091
VGSSPQRTGAHEQNP	KCNH8	966	Q96L42
ANAGPNHTITLPQNS	KIAA0319	531	Q5VV43
QGLHAEEAPSSEPQS	NACC1	131	Q96RE7